Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 7:40 p.m.

    📋 FORMA THERAPEUTICS HOLDINGS, INC. (FMTX) - Financial Results

    Filing Date: 2022-08-05

    Accepted: 2022-08-05 07:30:30

    Event Type: Financial Results

    Event Details:

    Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO)) (FMTX) Reports Q3 2022 Financial Results Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO)) (FMTX) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 395903
      • expected in late 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Loss From Operations 44.06K 97.41K $-53.35K -54.77%
    Other Income Interest Income 309.00 888.00 $-579.00 -65.20%
    Selected Balance Sheet Items Cash Equivalents Marketable Securities 395.90K 490.27K $-94.37K -19.25%
    Loss from Operations 53.00K 44.06K $8.94K +20.29%
    Interest Income 599.00 309.00 $290.00 +93.85%
    Other Income, Net 407.00 581.00 $-174.00 -29.95%
    Net Loss 52.58K 43.59K $8.99K +20.63%
    Cash and Marketable Securities 395.90K 490.27K $-94.37K -19.25%
    Accounts Payable 33.42K 35.02K $-1.60K -4.56%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO))
    • CIK: 0001538927
    • Ticker Symbol: FMTX
    • Period End Date: 2022-08-05
    • Document Type: 8-K

Search

News categories